Diabetic Kidney Disease (c. 2018)

Katherine R Tuttle

doi:10.1053/j.ackd.2018.01.006

Diabetic Kidney Disease (c. 2018)

Katherine R Tuttle

Research output: Contribution to journal › Editorial

2 Scopus citations

Original language	English
Pages (from-to)	119-120
Number of pages	2
Journal	Advances in Chronic Kidney Disease
Volume	25
Issue number	2
DOIs	https://doi.org/10.1053/j.ackd.2018.01.006
State	Published - Mar 2018

Access to Document

10.1053/j.ackd.2018.01.006

Cite this

@article{50292d9350714a499498101000d863ca,

title = "Diabetic Kidney Disease (c. 2018)",

author = "Tuttle, \{Katherine R\}",

note = "Financial Disclosure: Consultant for therapeutics for diabetic kidney disease - Eli Lilly and Company, Boehringer Ingelheim, Astra Zeneca, and Gilead.",

year = "2018",

month = mar,

doi = "10.1053/j.ackd.2018.01.006",

language = "English",

volume = "25",

pages = "119--120",

journal = "Advances in Chronic Kidney Disease",

issn = "1548-5595",

publisher = "W.B. Saunders",

number = "2",

}

TY - JOUR

T1 - Diabetic Kidney Disease (c. 2018)

AU - Tuttle, Katherine R

N1 - Financial Disclosure: Consultant for therapeutics for diabetic kidney disease - Eli Lilly and Company, Boehringer Ingelheim, Astra Zeneca, and Gilead.

PY - 2018/3

Y1 - 2018/3

UR - https://www.scopus.com/pages/publications/85044111295

U2 - 10.1053/j.ackd.2018.01.006

DO - 10.1053/j.ackd.2018.01.006

M3 - Editorial

C2 - 29580575

SN - 1548-5595

VL - 25

SP - 119

EP - 120

JO - Advances in Chronic Kidney Disease

JF - Advances in Chronic Kidney Disease

IS - 2

ER -

Diabetic Kidney Disease (c. 2018)

Access to Document

Other files and links

Cite this